A rapid health technology assessment of sintilimab combined with chemotherapy for locally advanced or metastatic non-small cell lung cancer

doi:10.3969/j.issn.1672-3384.2023.10.013

CHEN Xin-yi, ZHAO Cheng-cheng, XI Qing

Clinical Medication Journal ›› 2023, Vol. 21 ›› Issue (10) : 69-74.

PDF(564 KB)

Clinical Medication Journal ›› 2023, Vol. 21 ›› Issue (10) : 69-74. DOI: 10.3969/j.issn.1672-3384.2023.10.013

Original Article

A rapid health technology assessment of sintilimab combined with chemotherapy for locally advanced or metastatic non-small cell lung cancer

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 21(10): 69-74 https://doi.org/10.3969/j.issn.1672-3384.2023.10.013

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(564 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2023-06-19	2023-10-30
Issue Date
2023-10-30

Please choose a citation manager

Content to export